Eastman Chemical Company (EMN) Q4 2025 earnings summary

Executive summary

• Management focused on stabilizing core businesses, cost reduction, and volume growth through innovation and asset utilization amid a challenging macroeconomic environment.

• Operating cash flow approached $1 billion in 2025, reflecting strong cash generation despite weak demand and competitive pressures.

• Cost reduction initiatives exceeded targets, achieving $100 million in savings versus a $75 million goal, with further actions planned.

• Kingsport methanolysis facility surpassed operational goals, delivering $60 million incremental earnings and over 2.5x recycled content production versus 2024.

• Dividend was raised for the 16th consecutive year, with $500 million returned to shareholders via dividends and buybacks.

Financial highlights

• FY25 revenue was $8.75 billion, down from $9.38 billion in FY24; Q4 sales were $1.97 billion, down 12% from Q4 2024.

• Adjusted EBIT for FY25 was $930 million (10.6% margin), down from $1.3 billion (13.8% margin) in FY24.

• Adjusted EPS for FY25 was $5.42, down from $7.89 in FY24.

• Net cash from operating activities was $970 million in 2025, down from $1.29 billion in 2024.

• Variable compensation is expected to be a $50 million–$75 million headwind year-over-year, depending on performance.

Outlook and guidance

• 2026 priorities include further cost reductions ($125–$150 million), innovation-driven growth, improved manufacturing utilization, and targeted commercial expansion.

• Capital expenditures to be reduced to ~$400 million in 2026, ~$150 million below 2025.

• Q1 2026 adjusted EPS projected at $1.00–$1.20, excluding winter storm impacts.

• Operating cash flow for 2026 expected to be similar to 2025; no full-year adjusted EPS guidance due to macro uncertainty.

• No new capital projects planned for 2026; maintenance capital ~$350 million.